Pharma industry stocks gain on the BSE amid hopes of revenue growth
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Stocks related to the pharma industry were trading higher on the BSE, as Crisil in its latest report has said the Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 per cent in current fiscal (FY24) aided by a steady domestic growth and increased exports to regulated markets, even as semi-regulated markets face headwinds. It stated a study of 186 drug makers, which accounted for about half of the Rs 3.7 lakh crore annual revenue of the sector last fiscal, indicates as much.
Sun Pharmaceutical Industries is currently trading at Rs. 1151.25, up by 14.15 points or 1.24% from its previous closing of Rs. 1137.10 on the BSE.
Natco Pharma is currently trading at Rs. 822.65, up by 10.30 points or 1.27% from its previous closing of Rs. 812.35 on the BSE.
Aurobindo Pharma is currently trading at Rs. 868.05, up by 0.35 points or 0.04% from its previous closing of Rs. 867.70 on the BSE.
